Skip to main content

Dicerna Pharmaceuticals Inc

DRNADelisted Dec 28, 2021
Industry
Pharmaceutical Preparations
SEC CIK
0001399529

Dicerna Pharmaceuticals Inc was delisted on Dec 28, 2021; its insiders filed their last Form 4 on Dec 29, 2021; 173 institutions reported holding it in 13F filings for Q3 2021, worth $1.28B in total; Maverick Capital was the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Dicerna Pharmaceuticals Inc changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of DRNA: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders10−1
Shares2.00K0−2.00K (−100.0%)
Value$76.0K$0−$76.0K (−100.0%)

New holders (0)

Institutions that held Dicerna Pharmaceuticals Inc at the end of Q2 2022 but not at the end of Q1 2022.

None.

Sold out (1)

Institutions that held Dicerna Pharmaceuticals Inc at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of DRNA in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Close Asset Management Ltd2,000$76.0K